The following blog posts discuss the Center for Strategic & International Studies’ recently launched series of reports on U.S. tuberculosis (TB) efforts and a CSIS panel on the issue.

Global Health Technologies Coalition’s “Breakthroughs”: CSIS panel: R&D fundamental to meeting new global TB targets
“…CSIS hosted the panel on the occasion of the release of its summary report Strategic U.S. Leadership — Essential to Address the Global Tuberculosis Pandemic — which examines U.S. approaches to tackling TB both in the United States and abroad…” (6/11).

Center for Global Health Policy’s “Science Speaks”: Tuberculosis R&D must be U.S. diplomatic priority, say global health leaders
“…The report on TB R&D recommends the U.S. government engage in long-term TB research partnership initiatives with emerging economies, with the aim of creating or strengthening select TB research centers of excellence ‘through catalytic funding and expanded technical exchanges’…” (Aziz, 6/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.